JAGX Jaguar Health Inc: Nilai Akuntansi saben Saham

Logo grafis Jaguar Health, Inc. (JAGX)

A stable trend in book value per share confirms that Jaguar Health, Inc. (JAGX) is protecting its market share in the gastrointestinal therapy segment. Growth is supported by inelastic demand for Mytesi and a unique pricing policy. Patents for plant raw material extraction create a significant barrier to entry for competitors. Currently, this metric holds around 20.39, indicating a high level of asset coverage.

Jaguar Health Inc (JAGX): Nilai Buku Saham saka 04.07.2022 nganti 28.10.2026
Produk sing diprodhuksi Jaguar Health

When selecting an issuer, fundamental analysis relies on multiples that reflect the intrinsic value of a business relative to market quotes. This metric measures the portion of net equity attributable to a single share, which for Jaguar Health, Inc. (JAGX), given its strategy of monopolizing the botanical diarrhea therapy niche, confirms the actual volume of assets recorded in the final book value per share.